Who We Are
MedCara, LLC is a formulation and licensing biotechnology company. MedCara Pharmaceuticals seeks to discover, develop, and commercialize pharmaceutical formulations independently and with clinical and industry partners.
MedCara's proprietary, systematic, compounding-based platform, is designed to accelerate the discovery of new drug uses and to expand intellectual property coverage of drug candidate compounds and classes of related compounds. This approach has formed the basis for collaborations with physicians and clinics via the dispensing under prescription with contracted compounding pharmacies. MedCara retains royalty rights to downstream revenue generated by the compounding pharmacies.
MedCara's drug design approach combines diverse formulation technology disciplines and an integrated clinical organizational philosophy to increase the speed and success rate of new drug applications and development. Within a dynamic core framework of pharmacology, pharmaceutics, and biophysics, MedCara Pharmaceuticals and its prescriber relationships have developed a variety of proprietary drug formulations.
MedCara's flagship product is WartPEEL®, a topical treatment that eliminates planter and common warts. The Company has several other proprietary formulas in development.
Our Business Model
Please download our Business Model ( PDF)